{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T13:49:37Z","timestamp":1792763377863,"version":"4.5.0"},"reference-count":74,"publisher":"American Medical Association (AMA)","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"abstract":"<jats:sec id=\"ab-zoi230764-4\"><jats:title>Importance<\/jats:title><jats:p>Although the clinical utility of genome sequencing for critically ill children is well recognized, its utility for proactive pediatric screening is not well explored.<\/jats:p><\/jats:sec><jats:sec id=\"ab-zoi230764-5\"><jats:title>Objective<\/jats:title><jats:p>To evaluate molecular findings from screening ostensibly healthy children with genome sequencing compared with a gene panel for medically actionable pediatric conditions.<\/jats:p><\/jats:sec><jats:sec id=\"ab-zoi230764-6\"><jats:title>Design, Setting, and Participants<\/jats:title><jats:p>This case series study was conducted among consecutive, apparently healthy children undergoing proactive genetic screening for pediatric disorders by genome sequencing (n\u2009=\u2009562) or an exome-based panel of 268 genes (n\u2009=\u2009606) from March 1, 2018, through July 31, 2022.<\/jats:p><\/jats:sec><jats:sec id=\"ab-zoi230764-7\"><jats:title>Exposures<\/jats:title><jats:p>Genetic screening for pediatric-onset disorders using genome sequencing or an exome-based panel of 268 genes.<\/jats:p><\/jats:sec><jats:sec id=\"ab-zoi230764-8\"><jats:title>Main Outcomes and Measures<\/jats:title><jats:p>Molecular findings indicative of genetic disease risk.<\/jats:p><\/jats:sec><jats:sec id=\"ab-zoi230764-9\"><jats:title>Results<\/jats:title><jats:p>Of 562 apparently healthy children (286 girls [50.9%]; median age, 29 days [IQR, 9-117 days]) undergoing screening by genome sequencing, 46 (8.2%; 95% CI, 5.9%-10.5%) were found to be at risk for pediatric-onset disease, including 22 children (3.9%) at risk for high-penetrance disorders. Sequence analysis uncovered molecular diagnoses among 32 individuals (5.7%), while copy number variant analysis uncovered molecular diagnoses among 14 individuals (2.5%), including 4 individuals (0.7%) with chromosome scale abnormalities. Overall, there were 47 molecular diagnoses, with 1 individual receiving 2 diagnoses; of the 47 potential diagnoses, 22 (46.8%) were associated with high-penetrance conditions. Pathogenic variants in medically actionable pediatric genes were found in 6 individuals (1.1%), constituting 12.8% (6 of 47) of all diagnoses. At least 1 pharmacogenomic variant was reported for 89.0% (500 of 562) of the cohort. In contrast, of 606 children (293 girls [48.3%]; median age, 26 days [IQR, 10-67 days]) undergoing gene panel screening, only 13 (2.1%; 95% CI, 1.0%-3.3%) resulted in potential childhood-onset diagnoses, a significantly lower rate than those screened by genome sequencing (<jats:italic>P<\/jats:italic>\u2009&amp;amp;lt;\u2009.001).<\/jats:p><\/jats:sec><jats:sec id=\"ab-zoi230764-10\"><jats:title>Conclusions and Relevance<\/jats:title><jats:p>In this case series study, genome sequencing as a proactive screening approach for children, due to its unrestrictive gene content and technical advantages in comparison with an exome-based gene panel for medically actionable childhood conditions, uncovered a wide range of heterogeneous high-penetrance pediatric conditions that could guide early interventions and medical management.<\/jats:p><\/jats:sec>","DOI":"10.1001\/jamanetworkopen.2023.26445","type":"journal-article","created":{"date-parts":[[2023,7,31]],"date-time":"2023-07-31T15:34:27Z","timestamp":1690817667000},"page":"e2326445","source":"Crossref","is-referenced-by-count":28,"title":["At-Risk Genomic Findings for Pediatric-Onset Disorders From Genome Sequencing vs Medically Actionable Gene Panel in Proactive Screening of Newborns and Children"],"prefix":"10.1001","volume":"6","author":[{"given":"Jorune","family":"Balciuniene","sequence":"first","affiliation":[{"name":"PerkinElmer Genomics, PerkinElmer Inc, Pittsburgh, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruby","family":"Liu","sequence":"additional","affiliation":[{"name":"PerkinElmer Genomics, PerkinElmer Inc, Pittsburgh, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lora","family":"Bean","sequence":"additional","affiliation":[{"name":"PerkinElmer Genomics, PerkinElmer Inc, Pittsburgh, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fen","family":"Guo","sequence":"additional","affiliation":[{"name":"PerkinElmer Genomics, PerkinElmer Inc, Pittsburgh, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Babi Ramesh Reddy","family":"Nallamilli","sequence":"additional","affiliation":[{"name":"PerkinElmer Genomics, PerkinElmer Inc, Pittsburgh, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naga","family":"Guruju","sequence":"additional","affiliation":[{"name":"PerkinElmer Genomics, PerkinElmer Inc, Pittsburgh, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangwen","family":"Chen-Deutsch","sequence":"additional","affiliation":[{"name":"PerkinElmer Genomics, PerkinElmer Inc, Pittsburgh, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rizwan","family":"Yousaf","sequence":"additional","affiliation":[{"name":"PerkinElmer Genomics, PerkinElmer Inc, Pittsburgh, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristina","family":"Fura","sequence":"additional","affiliation":[{"name":"PerkinElmer Genomics, PerkinElmer Inc, Pittsburgh, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ephrem","family":"Chin","sequence":"additional","affiliation":[{"name":"PerkinElmer Genomics, PerkinElmer Inc, Pittsburgh, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abhinav","family":"Mathur","sequence":"additional","affiliation":[{"name":"PerkinElmer Genomics, PerkinElmer Inc, Pittsburgh, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeqiang","family":"Ma","sequence":"additional","affiliation":[{"name":"PerkinElmer Genomics, PerkinElmer Inc, Pittsburgh, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Carmichael","sequence":"additional","affiliation":[{"name":"ViaCord LLC, PerkinElmer Inc, Waltham, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"da Silva","sequence":"additional","affiliation":[{"name":"PerkinElmer Genomics, PerkinElmer Inc, Pittsburgh, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christin","family":"Collins","sequence":"additional","affiliation":[{"name":"PerkinElmer Genomics, PerkinElmer Inc, Pittsburgh, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madhuri","family":"Hegde","sequence":"additional","affiliation":[{"name":"PerkinElmer Genomics, PerkinElmer Inc, Pittsburgh, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2023,7,31]]},"reference":[{"issue":"5","key":"zoi230764r1","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1038\/s41436-018-0295-y","article-title":"Copy-number variants in clinical genome sequencing: deployment and interpretation for rare and undiagnosed disease.","volume":"21","author":"Gross","year":"2019","journal-title":"Genet Med"},{"issue":"11","key":"zoi230764r2","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1136\/jmedgenet-2018-105272","article-title":"Whole-genome sequencing analysis of CNV using low-coverage and paired-end strategies is efficient and outperforms array-based CNV analysis.","volume":"55","author":"Zhou","year":"2018","journal-title":"J Med Genet"},{"issue":"8","key":"zoi230764r3","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1002\/humu.2015.36.issue-8","article-title":"Comparison of exome and genome sequencing technologies for the complete capture of protein-coding regions.","volume":"36","author":"Lelieveld","year":"2015","journal-title":"Hum Mutat"},{"issue":"1","key":"zoi230764r4","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.cell.2019.02.032","article-title":"Genomic analysis in the age of human genome sequencing.","volume":"177","author":"Lappalainen","year":"2019","journal-title":"Cell"},{"issue":"7","key":"zoi230764r5","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1038\/s41576-018-0022-1","article-title":"First-line genomic diagnosis of mitochondrial disorders.","volume":"19","author":"Raymond","year":"2018","journal-title":"Nat Rev Genet"},{"issue":"7","key":"zoi230764r6","doi-asserted-by":"publisher","first-page":"e730","DOI":"10.1212\/WNL.0000000000200745","article-title":"Use of whole-genome sequencing for mitochondrial disease diagnosis.","volume":"99","author":"Davis","year":"2022","journal-title":"Neurology"},{"key":"zoi230764r7","doi-asserted-by":"publisher","first-page":"18.1","DOI":"10.1002\/0471142905.2018.96.issue-1","article-title":"Balanced chromosomal rearrangement detection by low-pass whole-genome sequencing.","volume":"96","author":"Dong","year":"2018","journal-title":"Curr Protoc Hum Genet"},{"issue":"3","key":"zoi230764r8","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/S1474-4422(21)00462-2","article-title":"Whole genome sequencing for the diagnosis of neurological repeat expansion disorders in the UK: a retrospective diagnostic accuracy and prospective clinical validation study.","volume":"21","author":"Iba\u00f1ez","year":"2022","journal-title":"Lancet Neurol"},{"key":"zoi230764r9","doi-asserted-by":"publisher","DOI":"10.1136\/bmj-2021-066288","article-title":"Use of whole genome sequencing to determine genetic basis of suspected mitochondrial disorders: cohort study.","volume":"375","author":"Schon","year":"2021","journal-title":"BMJ"},{"issue":"1","key":"zoi230764r10","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/s13073-021-00855-5","article-title":"Integration of whole genome sequencing into a healthcare setting: high diagnostic rates across multiple clinical entities in 3219 rare disease patients.","volume":"13","author":"Stranneheim","year":"2021","journal-title":"Genome Med"},{"issue":"1","key":"zoi230764r11","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1038\/s41431-020-00713-9","article-title":"Successful application of genome sequencing in a diagnostic setting: 1007 index cases from a clinically heterogeneous cohort.","volume":"29","author":"Bertoli-Avella","year":"2021","journal-title":"Eur J Hum Genet"},{"issue":"20","key":"zoi230764r12","doi-asserted-by":"publisher","first-page":"1868","DOI":"10.1056\/NEJMoa2035790","article-title":"100,000 Genomes pilot on rare-disease diagnosis in health care\u2014preliminary report.","volume":"385","author":"Smedley","year":"2021","journal-title":"N Engl J Med"},{"key":"zoi230764r13","doi-asserted-by":"publisher","DOI":"10.1038\/s41431-022-01226-3","article-title":"Genome sequencing with gene panel-based analysis for rare inherited conditions in a publicly funded healthcare system: implications for future testing.","author":"Hocking","year":"2023","journal-title":"Eur J Hum Genet"},{"key":"zoi230764r14","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1038\/s41525-018-0053-8","article-title":"Meta-analysis of the diagnostic and clinical utility of genome and exome sequencing and chromosomal microarray in children with suspected genetic diseases.","volume":"3","author":"Clark","year":"2018","journal-title":"NPJ Genom Med"},{"issue":"12","key":"zoi230764r15","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1136\/jmedgenet-2019-106111","article-title":"Case for genome sequencing in infants and children with rare, undiagnosed or genetic diseases.","volume":"56","author":"Bick","year":"2019","journal-title":"J Med Genet"},{"issue":"17","key":"zoi230764r16","doi-asserted-by":"publisher","first-page":"5473","DOI":"10.1073\/pnas.1418631112","article-title":"Whole-genome sequencing is more powerful than whole-exome sequencing for detecting exome variants.","volume":"112","author":"Belkadi","year":"2015","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"11","key":"zoi230764r17","doi-asserted-by":"publisher","first-page":"1328","DOI":"10.1038\/gim.2018.41","article-title":"Whole-genome sequencing offers additional but limited clinical utility compared with reanalysis of whole-exome sequencing.","volume":"20","author":"Alfares","year":"2018","journal-title":"Genet Med"},{"key":"zoi230764r18","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/j.mito.2021.01.006","article-title":"Comparison of whole genome sequencing and targeted sequencing for mitochondrial DNA.","volume":"58","author":"Chen","year":"2021","journal-title":"Mitochondrion"},{"issue":"4","key":"zoi230764r19","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1038\/s41397-022-00277-5","article-title":"Real-world economic evaluation of prospective rapid whole-genome sequencing compared to a matched retrospective cohort of critically ill pediatric patients in the United States.","volume":"22","author":"Diaby","year":"2022","journal-title":"Pharmacogenomics J"},{"issue":"7","key":"zoi230764r20","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1016\/j.ajhg.2021.05.008","article-title":"Project Baby Bear: rapid precision care incorporating rWGS in 5 California children\u2019s hospitals demonstrates improved clinical outcomes and reduced costs of care.","volume":"108","author":"Dimmock","year":"2021","journal-title":"Am J Hum Genet"},{"key":"zoi230764r21","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2021.809536","article-title":"Cost efficacy of rapid whole genome sequencing in the pediatric intensive care unit.","volume":"9","author":"Sanford Kobayashi","year":"2022","journal-title":"Front Pediatr"},{"issue":"4","key":"zoi230764r22","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1016\/j.ajhg.2019.08.009","article-title":"A randomized, controlled trial of the analytic and diagnostic performance of singleton and trio, rapid genome and exome sequencing in ill infants.","volume":"105","author":"Kingsmore","year":"2019","journal-title":"Am J Hum Genet"},{"issue":"1","key":"zoi230764r23","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1038\/s41436-018-0024-6","article-title":"Clinical application of genome and exome sequencing as a diagnostic tool for pediatric patients: a scoping review of the literature.","volume":"21","author":"Smith","year":"2019","journal-title":"Genet Med"},{"issue":"489","key":"zoi230764r24","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aat6177","article-title":"Diagnosis of genetic diseases in seriously ill children by rapid whole-genome sequencing and automated phenotyping and interpretation.","volume":"11","author":"Clark","year":"2019","journal-title":"Sci Transl Med"},{"key":"zoi230764r25","doi-asserted-by":"publisher","DOI":"10.1038\/s41390-022-02313-3","article-title":"Pharmacogenetic profiling via genome sequencing in children with medical complexity.","author":"Pan","year":"2023","journal-title":"Pediatr Res"},{"issue":"6","key":"zoi230764r26","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1016\/j.ajhg.2018.04.004","article-title":"Preconception carrier screening by genome sequencing: results from the clinical laboratory.","volume":"102","author":"Punj","year":"2018","journal-title":"Am J Hum Genet"},{"issue":"2","key":"zoi230764r27","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1093\/humupd\/dmaa044","article-title":"Preconception genome medicine: current state and future perspectives to improve infertility diagnosis and reproductive and health outcomes based on individual genomic data.","volume":"27","author":"Capalbo","year":"2021","journal-title":"Hum Reprod Update"},{"issue":"1","key":"zoi230764r28","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1186\/s13073-019-0682-2","article-title":"Low coverage whole genome sequencing enables accurate assessment of common variants and calculation of genome-wide polygenic scores.","volume":"11","author":"Homburger","year":"2019","journal-title":"Genome Med"},{"issue":"3","key":"zoi230764r29","doi-asserted-by":"publisher","first-page":"159","DOI":"10.7326\/M17-0188","article-title":"The impact of whole-genome sequencing on the primary care and outcomes of healthy adult patients: a pilot randomized trial.","volume":"167","author":"Vassy","year":"2017","journal-title":"Ann Intern Med"},{"issue":"14","key":"zoi230764r30","doi-asserted-by":"publisher","first-page":"3686","DOI":"10.1073\/pnas.1706096114","article-title":"Precision medicine screening using whole-genome sequencing and advanced imaging to identify disease risk in adults.","volume":"115","author":"Perkins","year":"2018","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"zoi230764r31","doi-asserted-by":"publisher","first-page":"3053","DOI":"10.1073\/pnas.1909378117","article-title":"Precision medicine integrating whole-genome sequencing, comprehensive metabolomics, and advanced imaging.","volume":"117","author":"Hou","year":"2020","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"zoi230764r32","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1007\/s00439-022-02480-7","article-title":"Genome screening, reporting, and genetic counseling for healthy populations.","volume":"142","author":"Casalino","year":"2023","journal-title":"Hum Genet"},{"issue":"12","key":"zoi230764r33","doi-asserted-by":"publisher","first-page":"1962","DOI":"10.3390\/jpm12121962","article-title":"Real-world results from combined screening for monogenic genomic health risks and reproductive risks in 300 adults.","volume":"12","author":"Wildin","year":"2022","journal-title":"J Pers Med"},{"issue":"3","key":"zoi230764r34","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1038\/gim.2015.111","article-title":"Utility of whole-genome sequencing for detection of newborn screening disorders in a population cohort of 1,696 neonates.","volume":"18","author":"Bodian","year":"2016","journal-title":"Genet Med"},{"key":"zoi230764r35","doi-asserted-by":"publisher","first-page":"S8","DOI":"10.1542\/peds.2015-3731D","article-title":"Whole-genome screening of newborns? the constitutional boundaries of state newborn screening programs.","volume":"137","author":"King","year":"2016","journal-title":"Pediatrics"},{"issue":"3","key":"zoi230764r36","doi-asserted-by":"publisher","first-page":"40","DOI":"10.3390\/ijns8030040","article-title":"Newborn screening by genomic sequencing: opportunities and challenges.","volume":"8","author":"Bick","year":"2022","journal-title":"Int J Neonatal Screen"},{"issue":"9","key":"zoi230764r37","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1016\/j.ajhg.2022.08.003","article-title":"A genome sequencing system for universal newborn screening, diagnosis, and precision medicine for severe genetic diseases.","volume":"109","author":"Kingsmore","year":"2022","journal-title":"Am J Hum Genet"},{"issue":"1","key":"zoi230764r39","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.ajhg.2018.11.016","article-title":"Interpretation of genomic sequencing results in healthy and ill newborns: results from the BabySeq Project.","volume":"104","author":"Ceyhan-Birsoy","year":"2019","journal-title":"Am J Hum Genet"},{"key":"zoi230764r40","doi-asserted-by":"publisher","journal-title":"Fly (Austin)","DOI":"10.4161\/fly.19695"},{"issue":"6","key":"zoi230764r41","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1016\/j.jmoldx.2020.03.008","article-title":"Low-pass genome sequencing: validation and diagnostic utility from 409 clinical cases of low-pass genome sequencing for the detection of copy number variants to replace constitutional microarray.","volume":"22","author":"Chaubey","year":"2020","journal-title":"J Mol Diagn"},{"issue":"8","key":"zoi230764r42","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1038\/gim.2016.215","article-title":"The next generation of population-based spinal muscular atrophy carrier screening: comprehensive pan-ethnic SMN1 copy-number and sequence variant analysis by massively parallel sequencing.","volume":"19","author":"Feng","year":"2017","journal-title":"Genet Med"},{"issue":"5","key":"zoi230764r43","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1016\/j.jmoldx.2020.01.015","article-title":"Survival motor neuron gene copy number analysis by exome sequencing: assisting spinal muscular atrophy diagnosis and carrier screening.","volume":"22","author":"Liu","year":"2020","journal-title":"J Mol Diagn"},{"issue":"11","key":"zoi230764r44","doi-asserted-by":"publisher","first-page":"1895","DOI":"10.1101\/gr.225672.117","article-title":"Detection of long repeat expansions from PCR-free whole-genome sequence data.","volume":"27","author":"Dolzhenko","year":"2017","journal-title":"Genome Res"},{"issue":"5","key":"zoi230764r45","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology.","volume":"17","author":"Richards","year":"2015","journal-title":"Genet Med"},{"issue":"2","key":"zoi230764r46","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1038\/s41436-019-0686-8","article-title":"Technical standards for the interpretation and reporting of constitutional copy-number variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics (ACMG) and the Clinical Genome Resource (ClinGen).","volume":"22","author":"Riggs","year":"2020","journal-title":"Genet Med"},{"issue":"1","key":"zoi230764r47","doi-asserted-by":"publisher","DOI":"10.1002\/cphg.v103.1","article-title":"Overview of specifications to the ACMG\/AMP variant interpretation guidelines.","volume":"103","author":"Harrison","year":"2019","journal-title":"Curr Protoc Hum Genet"},{"key":"zoi230764r48","doi-asserted-by":"publisher","journal-title":"Genet Med","DOI":"10.1016\/j.gim.2022.04.006"},{"issue":"4","key":"zoi230764r51","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1002\/ajmg.c.v181.4","article-title":"The CHD8 overgrowth syndrome: a detailed evaluation of an emerging overgrowth phenotype in 27 patients.","volume":"181","author":"Ostrowski","year":"2019","journal-title":"Am J Med Genet C Semin Med Genet"},{"issue":"12","key":"zoi230764r52","doi-asserted-by":"publisher","DOI":"10.1002\/mgg3.v8.12","article-title":"A follow-up study of a Chinese family with Waardenburg syndrome type II caused by a truncating mutation of MITF gene.","volume":"8","author":"Yang","year":"2020","journal-title":"Mol Genet Genomic Med"},{"issue":"7","key":"zoi230764r53","doi-asserted-by":"publisher","first-page":"1900","DOI":"10.1002\/ajmg.a.v191.7","article-title":"Jansen-de Vries syndrome: expansion of the PPM1D clinical and phenotypic spectrum in 34 families.","volume":"191","author":"Wojcik","year":"2023","journal-title":"Am J Med Genet A"},{"issue":"13","key":"zoi230764r54","doi-asserted-by":"publisher","first-page":"2846","DOI":"10.1182\/blood-2009-05-213025","article-title":"Role of TNFRSF13B variants in patients with common variable immunodeficiency.","volume":"114","author":"Mart\u00ednez-Pomar","year":"2009","journal-title":"Blood"},{"issue":"4","key":"zoi230764r55","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1093\/hmg\/dds484","article-title":"Haploinsufficiency at the human IFNGR2 locus contributes to mycobacterial disease.","volume":"22","author":"Kong","year":"2013","journal-title":"Hum Mol Genet"},{"issue":"7","key":"zoi230764r56","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.1016\/j.neuron.2021.12.035","article-title":"ASH1L haploinsufficiency results in autistic-like phenotypes in mice and links Eph receptor gene to autism spectrum disorder.","volume":"110","author":"Yan","year":"2022","journal-title":"Neuron"},{"issue":"3","key":"zoi230764r57","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/j.ejmg.2018.07.015","article-title":"NRXN1 deletion syndrome; phenotypic and penetrance data from 34 families.","volume":"62","author":"Al Shehhi","year":"2019","journal-title":"Eur J Med Genet"},{"issue":"6","key":"zoi230764r59","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1038\/gim.2012.164","article-title":"Estimates of penetrance for recurrent pathogenic copy-number variations.","volume":"15","author":"Rosenfeld","year":"2013","journal-title":"Genet Med"},{"issue":"4","key":"zoi230764r60","doi-asserted-by":"publisher","DOI":"10.1002\/jgm.v19.4","article-title":"Clinical and molecular cytogenetic analyses of four families with 1q21.1 microdeletion or microduplication.","volume":"19","author":"Wang","year":"2017","journal-title":"J Gene Med"},{"issue":"1","key":"zoi230764r61","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1186\/s12887-018-1200-1","article-title":"The BabySeq Project: implementing genomic sequencing in newborns.","volume":"18","author":"Holm","year":"2018","journal-title":"BMC Pediatr"},{"issue":"7","key":"zoi230764r62","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1038\/gim.2016.193","article-title":"A curated gene list for reporting results of newborn genomic sequencing.","volume":"19","author":"Ceyhan-Birsoy","year":"2017","journal-title":"Genet Med"},{"issue":"7","key":"zoi230764r63","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1038\/s41576-023-00574-0","article-title":"Mendelian inheritance revisited: dominance and recessiveness in medical genetics.","volume":"24","author":"Zschocke","year":"2023","journal-title":"Nat Rev Genet"},{"key":"zoi230764r64","doi-asserted-by":"publisher","journal-title":"Clin Genet","DOI":"10.1111\/cge.2017.92.issue-1"},{"key":"zoi230764r65","doi-asserted-by":"publisher","journal-title":"Prenat Diagn","DOI":"10.1002\/(ISSN)1097-0223"},{"key":"zoi230764r66","doi-asserted-by":"publisher","journal-title":"J Med Genet","DOI":"10.1136\/jmedgenet-2018-105463"},{"key":"zoi230764r67","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1111\/dmcn.2016.58.issue-S4","article-title":"Early intervention in neurodevelopmental disorders: underlying neural mechanisms.","volume":"58","author":"Cioni","year":"2016","journal-title":"Dev Med Child Neurol"},{"issue":"6","key":"zoi230764r68","doi-asserted-by":"publisher","first-page":"1400","DOI":"10.1002\/ajmg.a.v182.6","article-title":"Limitations of exome sequencing in detecting rare and undiagnosed diseases.","volume":"182","author":"Burdick","year":"2020","journal-title":"Am J Med Genet A"},{"issue":"36","key":"zoi230764r70","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.15585\/mmwr.mm6936a6","article-title":"Infants with congenital disorders identified through newborn screening\u2014United States, 2015-2017.","volume":"69","author":"Sontag","year":"2020","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"zoi230764r71","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2021.663752","article-title":"The use of whole genome and exome sequencing for newborn screening: challenges and opportunities for population health.","volume":"9","author":"Woerner","year":"2021","journal-title":"Front Pediatr"},{"issue":"7","key":"zoi230764r72","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2021.14336","article-title":"Principles of genomic newborn screening programs: a systematic review.","volume":"4","author":"Downie","year":"2021","journal-title":"JAMA Netw Open"},{"issue":"5","key":"zoi230764r73","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1038\/s41431-019-0547-6","article-title":"Primary care provider perspectives on using genomic sequencing in the care of healthy children.","volume":"28","author":"Joshi","year":"2020","journal-title":"Eur J Hum Genet"},{"issue":"5","key":"zoi230764r74","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2023.12231","article-title":"Perspectives of rare disease experts on newborn genome sequencing.","volume":"6","author":"Gold","year":"2023","journal-title":"JAMA Netw Open"},{"key":"zoi230764r58","volume-title":"GeneReviews","author":"Miceli","year":"2022"},{"key":"zoi230764r38","unstructured":"UK National Screening Committee. Implications of whole genome sequencing for newborn screening. Published July 8, 2021. Accessed June 5, 2023. https:\/\/www.gov.uk\/government\/publications\/implications-of-whole-genome-sequencing-for-newborn-screening"},{"key":"zoi230764r49","unstructured":"Social Science Statistics. Statistics calculators. Accessed June 23, 2023. https:\/\/www.socscistatistics.com\/tests\/"},{"key":"zoi230764r50","unstructured":"ViaCord. Whole genome sequencing for newborns and children. Accessed June 26, 2023. https:\/\/www.viacord.com\/other-services\/newborn-and-children-tests\/whole-genome-sequencing\/"},{"key":"zoi230764r69","unstructured":"Health Resources & Services Administration. Recommended uniform screening panel. Accessed June 5, 2023. https:\/\/www.hrsa.gov\/advisory-committees\/heritable-disorders\/rusp"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2807782\/balciuniene_2023_oi_230764_1689947061.44699.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,31]],"date-time":"2023-07-31T15:34:33Z","timestamp":1690817673000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2807782"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,31]]},"references-count":74,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2023,7,3]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2023.26445","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,31]]}}}